$10.00
Purpose: Inhibits mycobacterial cell wall synthesis for tuberculosis treatment.
Description
Pirazinamid (Pyrazinamide) Tablets 500 mg. №50
Ingredients:
Each tablet contains 500 mg of Pyrazinamide.
Dosage:
The recommended dosage is determined by a healthcare provider based on the condition being treated. It is typically taken once daily with food.
Indications:
Pirazinamid tablets are indicated for the treatment of tuberculosis in combination with other anti-tuberculosis medications.
Contraindications:
Do not use Pirazinamid if you have severe liver disease or a history of severe adverse reactions to the medication. It is important to inform your healthcare provider about any existing medical conditions before starting treatment.
Directions:
Take Pirazinamid exactly as prescribed by your doctor. Do not exceed the recommended dosage or change the dosing schedule without consulting your healthcare provider.
Scientific Evidence:
Studies have shown that Pyrazinamide is an essential component in the treatment of tuberculosis. Research published in the International Journal of Tuberculosis and Lung Disease demonstrated the efficacy of Pyrazinamide in shortening the duration of tuberculosis treatment.
Additional Information:
It is important to complete the full course of treatment with Pirazinamid as prescribed by your healthcare provider. If you experience any severe side effects or allergic reactions, seek medical attention immediately.
Pyrazinamide works by disrupting the synthesis of mycolic acid in the cell wall of the tuberculosis bacteria, leading to cell death. This mechanism of action makes it a crucial component in the multidrug treatment regimen for tuberculosis.
Clinical trials have shown that Pirazinamid, when used in combination with other first-line anti-tuberculosis drugs, significantly improves treatment outcomes and reduces the risk of developing drug-resistant strains of tuberculosis. This underscores the importance of adherence to the prescribed treatment regimen for optimal results.
Recent Reviews